Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-14T22:25:33.712Z Has data issue: false hasContentIssue false

Case–case–control study of risk factors for carbapenem-resistant Enterobacterales infections among hospitalized patients

Published online by Cambridge University Press:  14 July 2022

David M. Stuever
Affiliation:
Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio
Amy K. Ferketich
Affiliation:
Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio
Jiyoung Lee
Affiliation:
Division of Environmental Health Sciences, College of Public Health, The Ohio State University, Columbus, OhioInfectious Diseases Institute, The Ohio State University, Columbus, Ohio
Kurt B. Stevenson
Affiliation:
Division of Infectious Diseases, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OhioInfectious Diseases Institute, The Ohio State University, Columbus, Ohio
Thomas E. Wittum*
Affiliation:
Department of Veterinary Preventive Medicine, The Ohio State University, Columbus, OhioInfectious Diseases Institute, The Ohio State University, Columbus, Ohio
*
Author for correspondence: Dr. Thomas Wittum, Infectious Diseases Institute, The Ohio State University, 1920 Coffey Rd., Columbus, OH 43210. E-mail: wittum.1@osu.edu

Abstract

Objective:

To identify important risk factors for carbapenem-resistant Enterobacterales (CRE) infections among hospitalized patients.

Design:

We utilized a case–case–control design that compared patients with CRE infections to patients with carbapenem-susceptible Enterobacterales (CSE) infections and randomly selected controls during the period from January 2011 through December 2016.

Setting:

The study population was selected from patients at a large metropolitan tertiary-care and instructional medical center.

Patients:

Cases of CRE were defined as initial admission of adults diagnosed with a bacterial infection of an Enterobacterales species resistant clinically or through sensitivity testing to carbapenems 48 hours or more after admission. Cases of CSE were selected from the same patient population as the CRE cases within a 30-day window for admission, with diagnostic pathogens identified as susceptible to carbapenems. Controls were defined as adult patients admitted to any service within a 30-day window from a CRE case for >48 hours who did not meet either of the above case definitions during that admission.

Results:

Antibiotic exposure within 90 days prior to admission and length of hospital stay were both associated with increased odds of CRE and CSE infections compared to controls. Patients with CRE infections had >18 times greater odds of prior antibiotic exposure compared to patients with CSE infections.

Conclusions:

Antibiotic exposure and increased length of hospital stay may result in increased patient risk of developing an infection resistant to carbapenems and other β-lactams.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1.Demographic Information for 81 Patients With Carbapenem-Resistant Enterobacterales (CRE) Infections, 87 Patients With Carbapenem-Susceptible Enterobacterales (CSE) Infections, and 89 Control Patients at a Large, Metropolitan, Tertiary-Care Hospital

Figure 1

Table 2.Results of Ordinary Logistic Regression Models for Estimating the Unadjusted Odds Ratios for Various Demographic and Clinical Variables for 81 Patients With Carbapenem-Resistant Enterobacterales (CRE) Infections Compared to 89 Control Patients

Figure 2

Table 3.Results of Ordinary Logistic Regression Models for Estimating the Unadjusted Odds Ratios (OR) for Various Demographic and Clinical Variables for 87 Patients With Carbapenem-Susceptible Enterobacterales (CSE) Infections Compared to 89 Control Patients

Figure 3

Table 4.Results of Ordinary Logistic Regression Models for Estimating the Unadjusted Odds Ratios (OR) for Various Demographic and Clinical Variables for 81 Patients With Carbapenem-Resistant Enterobacterales (CRE) Infections Compared to 87 Patients With Carbapenem-Susceptible Enterobacterales (CSE) Infections

Figure 4

Table 5.Adjusted Odds Ratios (ORs) From Final Multivariable Logistic Regression Models Comparing 81 Carbapenem-Resistant Enterobacterales (CRE) and 87 Carbapenem-Susceptible Enterobacterales (CSE) Patients to 89 Control Patients